The table below shows SOLENO THERAPEUTICS INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$190.41M
-
-
-
-
-
Cost of revenue
$2.70M
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$40.63M
$78.57M
$25.19M
$15.27M
$21.45M
$23.19M
SG&A
$132.13M
SLNO annual revenue (10-K history)
SOLENO THERAPEUTICS INC reported annual revenue of $190.41M for fiscal year 2025. That is up 13024.2% from $1.45M in fiscal 2016. Over the 5 fiscal years shown, annual revenue grew from $3.00M (FY 2013) to $190.41M. Figures come from the company's audited annual reports as filed with the SEC.